Artgen Biotech PJSC (MIC:ABIO) Price-to-Tangible-Book : (As of Jun. 20, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Artgen Biotech PJSC Price-to-Tangible-Book?

As of today (2024-06-20), Artgen Biotech PJSC's share price is ₽92.02. Artgen Biotech PJSC's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was ₽-4.89. Hence, Artgen Biotech PJSC's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Artgen Biotech PJSC's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Artgen Biotech PJSC's highest Price to Tangible Book Ratio was 21.70. The lowest was 2.30. And the median was 3.96.

MIC:ABIO's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.65
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Artgen Biotech PJSC's share price is ₽92.02. Artgen Biotech PJSC's Book Value per Sharefor the quarter that ended in Jun. 2023 was ₽5.14. Hence, Artgen Biotech PJSC's P/B Ratio of today is 17.91.

Artgen Biotech PJSC Price-to-Tangible-Book Historical Data

The historical data trend for Artgen Biotech PJSC's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artgen Biotech PJSC Price-to-Tangible-Book Chart

Artgen Biotech PJSC Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Tangible-Book

Get a 7-Day Free Trial

Artgen Biotech PJSC Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Artgen Biotech PJSC's Price-to-Tangible-Book

For the Biotechnology subindustry, Artgen Biotech PJSC's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Artgen Biotech PJSC's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artgen Biotech PJSC's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Artgen Biotech PJSC's Price-to-Tangible-Book falls into.

Artgen Biotech PJSC Price-to-Tangible-Book Calculation

Artgen Biotech PJSC's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	92.02	/	-4.887
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Artgen Biotech PJSC Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Artgen Biotech PJSC's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Artgen Biotech PJSC (MIC:ABIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artgen Biotech PJSC (MIC:ABIO) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

Prospect of the 60th Anniversary, Moscow, RUS, 117036

Website

https://www.hsci.ru

Artgen Biotech PJSC formerly Human Stem Cells Institute PJSC is a biotechnology company. It is engaged in the drug discovery, research and development and marketing of proprietary products and services in the field of regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy, and biopharmaceutics. The company has developed Neovasculgen, which is a gene therapy drug for the treatment of Peripheral Arterial Disease, including Critical Limb Ischemia and also develops SPRS therapy which entails the use of autologous dermal fibroblasts to repair skin damage due to aging and other structural changes.